William Slayton, MD - Research

Research at a glance

Top areas of exploration

Hematopoietic Stem Cells , 12 publications
Bone Marrow Transplantation , 10 publications
Bone Marrow Cells , 9 publications
Hematopoietic Stem Cell Transplantation , 8 publications

Research activity

86 publications

2,301 citations

Why is this important?

Active clinical trials

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 3 Years - 29 Years
Sexes: All

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in P

This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 2 Years - 25 Years
Sexes: All

A Study Comparing Blinatumomab to Blinatumomab With Nivolumab in Patients With First Relapse B-ALL

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with鈥�

Investigator: William Slayton
Status: Accepting Candidates
Ages: 1 Year - 30 Years
Sexes: All

My publications

86 publications

2023

Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial.

The Lancet. Haematology

鈥�

2023

Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders

Pediatric Blood & Cancer

2023

Trends in Pediatric Cancer Care in Florida From 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population.

Cureus

鈥�

2022

Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin Lymphoma.

International journal of radiation oncology, biology, physics

鈥�

2022

Volunteer-Based Social Support Structures and Program Exposure Outcomes in an Adolescent Young Adult Palliative Care Peer Support Program.

Journal of palliative medicine

鈥�

网红黑料